Contineum Therapeutics, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $3.35-$13.56 |
Market Cap | $340M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 4 months ago
Contineum Therapeutics Reports Positive Topline Data From PIPE-791 Phase 1b PET Trial
Yahoo Finance • 5 months ago
Contineum Therapeutics Non-GAAP EPS of -$0.62
Yahoo Finance • 7 months ago
Contineum completes enrollment in Phase 1b PET trial cohorts
Yahoo Finance • 7 months ago
ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair
About
CEO | Mr. Carmine N. Stengone MBA, MS |
Address | 3565 General Atomics Court, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 41 |
